Laboratory of Epidemiology and Population Sciences, National Institutes on Aging, NIA/NIH/IRP, Baltimore, MD, USA.
Department of Research Programs, Fort Belvoir Community Hospital, Fort Belvoir, VA, USA.
J Alzheimers Dis. 2020;75(1):157-172. doi: 10.3233/JAD-200064.
Microbial agents including periodontal pathogens have recently appeared as important actors in Alzheimer's disease (AD) pathology. We examined associations of clinical periodontal and bacterial parameters with incident all-cause and AD dementia as well as AD mortality among US middle-aged and older adults. Clinical [Attachment Loss (AL); probing pocket depth (PPD)] and bacterial [pathogen immunoglobulin G (IgG)] periodontal markers were investigated in relation to AD and all-cause dementia incidence and to AD mortality, using data from the third National Health and Nutrition Examination Surveys (NHANES III, 1988-1994) linked longitudinally with National Death Index and Medicare data through January 1, 2014, with up to 26 years of follow-up. Sex- and age-specific multivariable-adjusted Cox proportional hazards models were conducted. Among those ≥65 years, AD incidence and mortality were consistently associated with PPD, two factors and one cluster comprised of IgG titers against Porphyromonas gingivalis (P. gingivalis), Prevotella melaninogenica (P. melaninogenica) and Campylobacter rectus (C. rectus) among others. Specifically, AD incidence was linked to a composite of C. rectus and P. gingivalis titers (per SD, aHR = 1.22; 95% CI, 1.04-1.43, p = 0.012), while AD mortality risk was increased with another composite (per SD, aHR = 1.46; 95% CI, 1.09-1.96, p = 0.017) loading highly on IgG for P. gingivalis, Prevotella intermedia, Prevotella nigrescens, Fusobacterium nucleatum, C. rectus, Streptococcus intermedius, Capnocylophaga Ochracea, and P. melaninogenica. This study provides evidence for an association between periodontal pathogens and AD, which was stronger for older adults. Effectiveness of periodontal pathogen treatment on reducing sequelae of neurodegeneration should be tested in randomized controlled trials.
微生物制剂,包括牙周病原体,最近被认为是阿尔茨海默病(AD)发病机制中的重要因素。我们研究了美国中老年人的临床牙周和细菌参数与全因和 AD 痴呆以及 AD 死亡率的相关性。使用来自第三次全国健康和营养检查调查(NHANES III,1988-1994 年)的数据,通过与国家死亡指数和医疗保险数据纵向关联,截至 2014 年 1 月 1 日,最长随访 26 年,调查了临床[附着丧失(AL);探查袋深度(PPD)]和细菌[病原体免疫球蛋白 G(IgG)]牙周标志物与 AD 和全因痴呆的发生以及 AD 死亡率的相关性。进行了性别和年龄特异性多变量调整 Cox 比例风险模型。在≥65 岁的人群中,PPD、两种因素以及一种包含牙龈卟啉单胞菌(P. gingivalis)、牙髓卟啉单胞菌(P. melaninogenica)和直肠弯曲菌(C. rectus)等 IgG 滴度的聚类与 AD 发病率和死亡率始终相关。具体而言,AD 发病率与直肠弯曲菌和牙龈卟啉单胞菌滴度的复合指标相关(每标准差,aHR=1.22;95%CI,1.04-1.43,p=0.012),而 AD 死亡率风险增加与另一个复合指标相关(每标准差,aHR=1.46;95%CI,1.09-1.96,p=0.017),该指标高度加载了对牙龈卟啉单胞菌、中间普雷沃菌、黑普雷沃菌、具核梭杆菌、直肠弯曲菌、中间链球菌、黄色颗粒卟啉单胞菌和牙髓卟啉单胞菌的 IgG。这项研究为牙周病原体与 AD 之间的关联提供了证据,对于老年人而言,这种关联更强。应在随机对照试验中测试牙周病原体治疗对减少神经退行性病变后果的有效性。